Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Open accessThe DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers in western countries, with a median survival of 6 months and an extremely low percentage of long-term surviving patients. KRAS mutations are known to be a driver event of PDAC, but targeting mutant KRAS has proved challenging. Targeting oncogene-driven signalling pathways is a clinically validated approach for several devastating diseases. Still, despite marked tumour shrinkage, the frequency of relapse indicates that a fraction of tumour cells survives shut down of oncogenic signalling. Here we explore the role of mutant KRAS in PDAC maintenance using a recently developed inducible mouse model of mutated Kras (Kras(G12D), herein KRas) in a p53(LoxP/WT) background. We demonstrate that a subpopulation of dormant tumour cells surviving oncogene ablation (surviving cells) and responsible for tumour relapse has features of cancer stem cells and relies on oxidative phosphorylation for survival. Transcriptomic and metabolic analyses of surviving cells reveal prominent expression of genes governing mitochondrial function, autophagy and lysosome activity, as well as a strong reliance on mitochondrial respiration and a decreased dependence on glycolysis for cellular energetics. Accordingly, surviving cells show high sensitivity to oxidative phosphorylation inhibitors, which can inhibit tumour recurrence. Our integrated analyses illuminate a therapeutic strategy of combined targeting of the KRAS pathway and mitochondrial respiration to manage pancreatic cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prior studies have demonstrated that genetic ablation of KRAS expression leads to cell cycle arrest and death in cell lines and potent tumor regressions in animal models of PDAC (5–7).”
From Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer (2024) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with this notion, other complex I inhibitors have shown efficacy as anti-tumor agents (Appleyard et al., 2012; Schockel et al., 2015) and may show selective toxicity against oncogene-ablation resistant cells (Viale et al., 2014) and cancer stem cells (Sancho et al., 2015).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Viale et al., 2014
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A recurrent theme in studies on cancer progression is the increased reliance of cancer cells on OXPHOS in advanced stages of disease.”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [103]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast to the proliferating bulk of a tumor, accumulating evidence suggests that quiescent subpopulations of tumor cells are markedly less glycolytic and exhibit higher dependence on oxidative phosphorylation, as well as elevated expression of mitochondrial respiratory components.”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Viale et al., 2014
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In a mouse pancreatic cancer model, ablating oncogenic Kras from established tumors revealed a fraction of cells that survive and eventually propagate.”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [103]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Autophagy regulates lipid metabolism
Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K., Cuervo, A. M., & Czaja, M. J. (2009) · Nature · doi:10.1038/nature07976 · Cited by 3,975
Self-citationTransmission Electron Microscopy
Williams, D. B., & Carter, C. B. (2009) · Springer eBooks · doi:10.1007/978-0-387-76501-3 · Cited by 3,963
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,339
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
Hermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M., Bruns, C. J., & Heeschen, C. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.06.002 · Cited by 2,897
Updated research nosology for HIV-associated neurocognitive disorders
Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., Clifford, D. B., Cinque, P., Epstein, L. G., Goodkin, K., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000287431.88658.8b · Cited by 2,630
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.058 · Cited by 2,043
Self-citationHematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
Kantarjian, H., Sawyers, C., Hochhaus, A., Guilhot, F., Schiffer, C., Gambacorti-Passerini, C., Niederwieser, D., Resta, D., Capdeville, R., Zoellner, U., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011573 · Cited by 2,019
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., et al. (2013) · Nature · doi:10.1038/nature12040 · Cited by 1,990
Self-citation
Cited by
Items 101–200 of 1,000
Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis
Del Poggetto, E., Ho, I.-L., Balestrieri, C., Yen, E.-Y., Zhang, S., Citron, F., Shah, R., Corti, D., Diaferia, G. R., Li, C.-Y., et al. (2021) · Science · doi:10.1126/science.abj0486 · Cited by 253
Self-citationAn Overview: The Diversified Role of Mitochondria in Cancer Metabolism
Liu, Y., Sun, Y., Guo, Y., Shi, X., Chen, X., Feng, W., Wu, L.-L., Zhang, J., Yu, S., Wang, Y., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.81609 · Cited by 247
Self-citationOncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Santana-Codina, N., Roeth, A. A., Zhang, Y., Yang, A., Mashadova, O., Asara, J. M., Wang, X., Bronson, R. T., Lyssiotis, C. A., Ying, H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07472-8 · Cited by 252
Self-citationTranslational advances in pancreatic ductal adenocarcinoma therapy
Hosein, A. N., Dougan, S. K., Aguirre, A. J., & Maitra, A. (2022) · Nature Cancer · doi:10.1038/s43018-022-00349-2 · Cited by 250
Cárdenas, C., Müller, M., McNeal, A., Lovy, A., Jaňa, F., Bustos, G., Urra, F., Smith, N., Molgó, J., Diehl, J. A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.030 · Cited by 247
Emerging role of lipid metabolism alterations in Cancer stem cells
Yi, M., Li, J., Chen, S., Cai, J., Ban, Y., Peng, Q., Zhou, Y., Zeng, Z., Peng, S., Li, X., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0784-5 · Cited by 248
The carnitine system and cancer metabolic plasticity
Melone, M. A. B., Valentino, A., Margarucci, S., Galderisi, U., Giordano, A., & Peluso, G. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0313-7 · Cited by 246
Jones, C. L., Stevens, B. M., Pollyea, D. A., Culp-Hill, R., Reisz, J. A., Nemkov, T., Gehrke, S., Gamboni, F., Krug, A., Winters, A., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.07.021 · Cited by 238
Heterogeneity in Cancer Metabolism: New Concepts in an Old Field
Gentric, G., Mieulet, V., & Mechta-Grigoriou, F. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6750 · Cited by 240
Murata, M. M., Kong, X., Moncada, E., Chen, Y., Imamura, H., Wang, P., Berns, M. W., Yokomori, K., & Digman, M. A. (2019) · Molecular Biology of the Cell · doi:10.1091/mbc.e18-10-0650 · Cited by 232
Molecular Pathogenesis of Pancreatic Cancer
Grant, T. J., Hua, K., & Singh, A. (2016) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2016.09.008 · Cited by 237
Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment
Kerk, S. A., Papagiannakopoulos, T., Shah, Y. M., & Lyssiotis, C. A. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00375-9 · Cited by 237
Self-citationMetformin Targets Central Carbon Metabolism and Reveals Mitochondrial Requirements in Human Cancers
Liu, X., Romero, I. L., Litchfield, L. M., Lengyel, E., & Locasale, J. W. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.005 · Cited by 236
Zeh, H. J., Bahary, N., Boone, B. A., Singhi, A. D., Miller-Ocuin, J. L., Normolle, D. P., Zureikat, A. H., Hogg, M. E., Bartlett, D. L., Lee, K. K., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-4042 · Cited by 233
Targeting Drug Chemo-Resistance in Cancer Using Natural Products
Talib, W. H., Alsayed, A. R., Barakat, M., Abu-Taha, M. I., & Mahmod, A. I. (2021) · Biomedicines · doi:10.3390/biomedicines9101353 · Cited by 231
Cancer stem cell metabolism: a potential target for cancer therapy
Deshmukh, A., Deshpande, K., Arfuso, F., Newsholme, P., & Dharmarajan, A. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0555-x · Cited by 228
Cancer Metabolism: Current Understanding and Therapies
Counihan, J. L., Grossman, E. A., & Nomura, D. K. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00775 · Cited by 226
Metabolic Dependencies in RAS-Driven Cancers
Kimmelman, A. C. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2425 · Cited by 224
Self-citationRegulation of Tumor Progression by Programmed Necrosis
Lee, S. Y., Ju, M. K., Jeon, H. M., Jeong, E. K., Lee, Y. J., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/3537471 · Cited by 215
Fumarate is a terminal electron acceptor in the mammalian electron transport chain
Spinelli, J. B., Rosen, P. C., Sprenger, H.-G., Puszynska, A. M., Mann, J. L., Roessler, J. M., Cangelosi, A. L., Henne, A., Condon, K. J., Zhang, T., et al. (2021) · Science · doi:10.1126/science.abi7495 · Cited by 221
Functions of autophagy in the tumor microenvironment and cancer metastasis
Mowers, E. E., Sharifi, M. N., & Macleod, K. F. (2018) · The FEBS Journal · doi:10.1111/febs.14388 · Cited by 221
The Warburg metabolism fuels tumor metastasis
Lu, J. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-019-09794-5 · Cited by 218
Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up
Perera, R. M., & Bardeesy, N. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0671 · Cited by 217
Therapeutic strategies targeting cancer stem cells
Yoshida, G. J., & Saya, H. (2016) · Cancer Science · doi:10.1111/cas.12817 · Cited by 214
Fox, D. B., Garcia, N. M. G., McKinney, B. J., Lupo, R., Noteware, L. C., Newcomb, R., Liu, J., Locasale, J. W., Hirschey, M. D., & Alvarez, J. V. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0191-z · Cited by 210
Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer
Yao, W., Rose, J. L., Wang, W., Seth, S., Jiang, H., Taguchi, A., Liu, J., Yan, L., Kapoor, A., Hou, P., et al. (2019) · Nature · doi:10.1038/s41586-019-1062-1 · Cited by 214
Self-citationDey, P., Li, J., Zhang, J., Chaurasiya, S., Strom, A., Wang, H., Liao, W.-T., Cavallaro, F., Denz, P., Bernard, V., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0297 · Cited by 213
“0001 **** Two-sided Low (1) Medium (2) High (3) N-Normal T-Tumor S eg ar a”
BackgroundSelf-citationMikubo, M., Inoue, Y., Liu, G., & Tsao, M.-S. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.07.017 · Cited by 208
Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance
De Angelis, M. L., Francescangeli, F., La Torre, F., & Zeuner, A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00626 · Cited by 206
HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models
Nguyen, T. T. T., Zhang, Y., Shang, E., Shu, C., Torrini, C., Zhao, J., Bianchetti, E., Mela, A., Humala, N., Mahajan, A., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci129049 · Cited by 201
Chen, J., Guccini, I., Di Mitri, D., Brina, D., Revandkar, A., Sarti, M., Pasquini, E., Alajati, A., Pinton, S., Losa, M., et al. (2018) · Nature Genetics · doi:10.1038/s41588-017-0026-3 · Cited by 194
Self-citationFranco, J., Balaji, U., Freinkman, E., Witkiewicz, A. K., & Knudsen, E. S. (2016) · Cell Reports · doi:10.1016/j.celrep.2015.12.094 · Cited by 199
“Key downstream effectors include MEK and MTOR signaling pathways that engage multiple distal features of metabolism through transcriptional and translational regulatory programs (Laplante and Sabatini, 2009, 2012; Viale et al., 2014; Ying et al., 2012).”
Oncogenic KRAS induces NIX-mediated mitophagy to promote pancreatic cancer
Humpton, T. J., Alagesan, B., DeNicola, G. M., Lu, D., Yordanov, G. N., Leonhardt, C. S., Yao, M. A., Alagesan, P., Zaatari, M. N., Park, Y., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1409 · Cited by 198
Makinoshima, H., Takita, M., Saruwatari, K., Umemura, S., Obata, Y., Ishii, G., Matsumoto, S., Sugiyama, E., Ochiai, A., Abe, R., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.660498 · Cited by 193
PI3K therapy reprograms mitochondrial trafficking to fuel tumor cell invasion
Caino, M. C., Ghosh, J. C., Chae, Y. C., Vaira, V., Rivadeneira, D. B., Faversani, A., Rampini, P., Kossenkov, A. V., Aird, K. M., Zhang, R., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500722112 · Cited by 197
KRAS drives immune evasion in a genetic model of pancreatic cancer
Ischenko, I., D’Amico, S., Rao, M., Li, J., Hayman, M. J., Powers, S., Petrenko, O., & Reich, N. C. (2021) · Nature Communications · doi:10.1038/s41467-021-21736-w · Cited by 191
Patra, K. C., Kato, Y., Mizukami, Y., Widholz, S., Boukhali, M., Revenco, I., Grossman, E. A., Ji, F., Sadreyev, R. I., Liss, A. S., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0122-3 · Cited by 192
Corbet, C., Bastien, E., Draoui, N., Doix, B., Mignion, L., Jordan, B. F., Marchand, A., Vanherck, J.-C., Chaltin, P., Schakman, O., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03525-0 · Cited by 188
Manipulation of Mitophagy by “All-in-One” nanosensitizer augments sonodynamic glioma therapy
Qu, F., Wang, P., Zhang, K., Shi, Y., Li, Y., Li, C., Lu, J., Liu, Q., & Wang, X. (2020) · Autophagy · doi:10.1080/15548627.2019.1687210 · Cited by 191
Emerging Insights into Targeted Therapy-Tolerant Persister Cells in Cancer
Cabanos, H. F., & Hata, A. N. (2021) · Cancers · doi:10.3390/cancers13112666 · Cited by 189
“In cancer, the term “persister” has no clear biological definition and the term is used interchangeably with other terms such as tolerant [23,25,40], dormant [52], or quiescent [53] to refer to sub-populations of cancer cells that survive prolonged drug treatment [54].”
BackgroundThe Role of PGC1α in Cancer Metabolism and its Therapeutic Implications
Tan, Z., Luo, X., Xiao, L., Tang, M., Bode, A. M., Dong, Z., & Cao, Y. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0621 · Cited by 189
KRAS-related proteins in pancreatic cancer
Mann, K. M., Ying, H., Juan, J., Jenkins, N. A., & Copeland, N. G. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.09.003 · Cited by 187
Self-citationExpanding perspectives on the significance of mitophagy in cancer
Drake, L. E., Springer, M. Z., Poole, L. P., Kim, C. J., & Macleod, K. F. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.04.008 · Cited by 184
Infiltrative and drug‐resistant slow‐cycling cells support metabolic heterogeneity in glioblastoma
Hoang‐Minh, L. B., Siebzehnrubl, F. A., Yang, C., Suzuki‐Hatano, S., Dajac, K., Loche, T., Andrews, N., Schmoll Massari, M., Patel, J., Amin, K., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201798772 · Cited by 185
Cancer stem cell metabolism: target for cancer therapy
Chae, Y. C., & Kim, J. H. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.7.112 · Cited by 184
The Mitochondrial Unfoldase-Peptidase Complex ClpXP Controls Bioenergetics Stress and Metastasis
Seo, J. H., Rivadeneira, D. B., Caino, M. C., Chae, Y. C., Speicher, D. W., Tang, H.-Y., Vaira, V., Bosari, S., Palleschi, A., Rampini, P., et al. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002507 · Cited by 179
Autophagy as a therapeutic target in pancreatic cancer
Piffoux, M., Eriau, E., & Cassier, P. A. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01039-5 · Cited by 181
Drug-tolerant persister cells in cancer: the cutting edges and future directions
Pu, Y., Li, L., Peng, H., Liu, L., Heymann, D., Robert, C., Vallette, F., & Shen, S. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00815-5 · Cited by 175
Metabolic Heterogeneity of Cancer Cells: An Interplay between HIF-1, GLUTs, and AMPK
Moldogazieva, N. T., Mokhosoev, I. M., & Terentiev, A. A. (2020) · Cancers · doi:10.3390/cancers12040862 · Cited by 177
Linking metabolic reprogramming to therapy resistance in cancer
Morandi, A., & Indraccolo, S. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.12.004 · Cited by 177
Survival of pancreatic cancer cells lacking KRAS function
Muzumdar, M. D., Chen, P.-Y., Dorans, K. J., Chung, K. M., Bhutkar, A., Hong, E., Noll, E. M., Sprick, M. R., Trumpp, A., & Jacks, T. (2017) · Nature Communications · doi:10.1038/s41467-017-00942-5 · Cited by 177
Maya-Mendoza, A., Ostrakova, J., Kosar, M., Hall, A., Duskova, P., Mistrik, M., Merchut-Maya, J. M., Hodny, Z., Bartkova, J., Christensen, C., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2014.11.001 · Cited by 176
Harnessing metabolic dependencies in pancreatic cancers
Encarnación-Rosado, J., & Kimmelman, A. C. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00431-7 · Cited by 174
Self-citationTargeting Mitochondrial Complex I Overcomes Chemoresistance in High OXPHOS Pancreatic Cancer
Masoud, R., Reyes-Castellanos, G., Lac, S., Garcia, J., Dou, S., Shintu, L., Abdel Hadi, N., Gicquel, T., El Kaoutari, A., Diémé, B., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100143 · Cited by 175
Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities
Lanning, N. J., Castle, J. P., Singh, S. J., Leon, A. N., Tovar, E. A., Sanghera, A., MacKeigan, J. P., Filipp, F. V., & Graveel, C. R. (2017) · Cancer & Metabolism · doi:10.1186/s40170-017-0168-x · Cited by 175
Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer
Yu, M., Nguyen, N. D., Huang, Y., Lin, D., Fujimoto, T. N., Molkentine, J. M., Deorukhkar, A., Kang, Y., San Lucas, F. A., Fernandes, C. J., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126915 · Cited by 173
Self-citationCancer cell metabolism and mitochondria: Nutrient plasticity for TCA cycle fueling
Corbet, C., & Feron, O. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.01.002 · Cited by 172
PKM1 Confers Metabolic Advantages and Promotes Cell-Autonomous Tumor Cell Growth
Morita, M., Sato, T., Nomura, M., Sakamoto, Y., Inoue, Y., Tanaka, R., Ito, S., Kurosawa, K., Yamaguchi, K., Sugiura, Y., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.02.004 · Cited by 171
A promising new approach to cancer therapy: Targeting iron metabolism in cancer stem cells
El Hout, M., Dos Santos, L., Hamaï, A., & Mehrpour, M. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.07.009 · Cited by 168
Metabolic shifts in residual breast cancer drive tumor recurrence
Havas, K. M., Milchevskaya, V., Radic, K., Alladin, A., Kafkia, E., Garcia, M., Stolte, J., Klaus, B., Rotmensz, N., Gibson, T. J., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89914 · Cited by 168
Ge, Q., Jia, D., Cen, D., Qi, Y., Shi, C., Li, J., Sang, L., Yang, L.-J., He, J., Lin, A., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci152911 · Cited by 160
Autophagy in colorectal cancer: An important switch from physiology to pathology
Burada, F. (2015) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v7.i11.271 · Cited by 167
Denise, C., Paoli, P., Calvani, M., Taddei, M. L., Giannoni, E., Kopetz, S., Kazmi, S. M. A., Pia, M. M., Pettazzoni, P., Sacco, E., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5991 · Cited by 164
Self-citationImpact of cancer metabolism on therapy resistance – Clinical implications
Gonçalves, A. C., Richiardone, E., Jorge, J., Polónia, B., Xavier, C. P. R., Salaroglio, I. C., Riganti, C., Vasconcelos, M. H., Corbet, C., & Sarmento-Ribeiro, A. B. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100797 · Cited by 164
Gain-of-Function Mutant p53: All the Roads Lead to Tumorigenesis
Stein, Y., Rotter, V., & Aloni-Grinstein, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246197 · Cited by 162
Regulation and function of autophagy in pancreatic cancer
Li, J., Chen, X., Kang, R., Zeh, H., Klionsky, D. J., & Tang, D. (2021) · Autophagy · doi:10.1080/15548627.2020.1847462 · Cited by 162
The Genomic Landscape of Renal Oncocytoma Identifies a Metabolic Barrier to Tumorigenesis
Joshi, S., Tolkunov, D., Aviv, H., Hakimi, A. A., Yao, M., Hsieh, J. J., Ganesan, S., Chan, C. S., & White, E. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.059 · Cited by 161
A neuronal network of mitochondrial dynamics regulates metastasis
Caino, M. C., Seo, J. H., Aguinaldo, A., Wait, E., Bryant, K. G., Kossenkov, A. V., Hayden, J. E., Vaira, V., Morotti, A., Ferrero, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms13730 · Cited by 161
Bosc, C., Broin, N., Fanjul, M., Saland, E., Farge, T., Courdy, C., Batut, A., Masoud, R., Larrue, C., Skuli, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17882-2 · Cited by 159
Mitochondria, cholesterol and cancer cell metabolism
Ribas, V., García‐Ruiz, C., & Fernández‐Checa, J. C. (2016) · Clinical and Translational Medicine · doi:10.1186/s40169-016-0106-5 · Cited by 159
Lipid metabolism alteration contributes to and maintains the properties of cancer stem cells
Li, H., Feng, Z., & He, M.-L. (2020) · Theranostics · doi:10.7150/thno.41388 · Cited by 159
Lee, S., & Griffiths, J. R. (2020) · Cancers · doi:10.3390/cancers12061616 · Cited by 179
Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy
Li, J., Eu, J. Q., Kong, L. R., Wang, L., Lim, Y. C., Goh, B. C., & Wong, A. L. A. (2020) · Molecules · doi:10.3390/molecules25204831 · Cited by 159
Why All the Fuss about Oxidative Phosphorylation (OXPHOS)?
Xu, Y., Xue, D., Bankhead, A., & Neamati, N. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01013 · Cited by 159
Mitochondrial ClpP serine protease-biological function and emerging target for cancer therapy
Nouri, K., Feng, Y., & Schimmer, A. D. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03062-z · Cited by 163
Yuan, M., Kremer, D. M., Huang, H., Breitkopf, S. B., Ben-Sahra, I., Manning, B. D., Lyssiotis, C. A., & Asara, J. M. (2019) · Nature Protocols · doi:10.1038/s41596-018-0102-x · Cited by 152
Self-citationTumor Microenvironment Remodeling Enables Bypass of Oncogenic KRAS Dependency in Pancreatic Cancer
Hou, P., Kapoor, A., Zhang, Q., Li, J., Wu, C.-J., Li, J., Lan, Z., Tang, M., Ma, X., Ackroyd, J. J., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0597 · Cited by 154
“S8B), and in PDAC surviving cells after KRAS* ablation in 349 iKPC model (36) (Supplementary Fig.”
BackgroundSelf-citationIntratumoral Heterogeneity: From Diversity Comes Resistance
Pribluda, A., de la Cruz, C. C., & Jackson, E. L. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1213 · Cited by 153
Jones, C. L., Sheth, A. I., & Jordan, C. T. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.02.013 · Cited by 175
Zaytseva, Y. Y., Harris, J. W., Mitov, M. I., Kim, J. T., Butterfield, D. A., Lee, E. Y., Weiss, H. L., Gao, T., & Evers, B. M. (2015) · Oncotarget · doi:10.18632/oncotarget.3783 · Cited by 153
Valle, S., Alcalá, S., Martín-Hijano, L., Cabezas‐Sainz, P., Navarro, D., Muñoz, E. R., Yuste, L., Tiwary, K., Walter, K., Ruíz-Cañas, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18954-z · Cited by 172
Li, Y., Xia, J., Shao, F., Zhou, Y., Yu, J., Wu, H., Du, J., & Ren, X. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.10.083 · Cited by 161
Glioblastoma Stem-Like Cells, Metabolic Strategy to Kill a Challenging Target
Garnier, D., Renoult, O., Alves‐Guerra, M., Paris, F., & Pecqueur, C. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00118 · Cited by 170
Differential effector engagement by oncogenic KRAS
Yuan, T. L., Amzallag, A., Bagni, R., Yi, M., Afghani, S., Burgan, W., Fer, N., Strathern, L. A., Powell, K., Smith, B., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.051 · Cited by 150
Al-Khami, A. A., Hossain, F., Wyczechowska, D., Hernandez, C., Zheng, L., Reiss, K., Del Valle, L., Trillo-Tinoco, J., Maj, T., Zou, W., et al. (2015) · Journal for ImmunoTherapy of Cancer · doi:10.1186/2051-1426-3-s2-o18 · Cited by 150
Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism
Li, S., Ma, J., & Wong, A. S. T. (2018) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2018.29.e32 · Cited by 152
Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells
Ippolito, L., Marini, A., Cavallini, L., Morandi, A., Pietrovito, L., Pintus, G., Giannoni, E., Schrader, T. H., Puhr, M., Chiarugi, P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11301 · Cited by 149
Metabolism-Based Therapeutic Strategies Targeting Cancer Stem Cells
Jagušt, P., de Luxán‐Delgado, B., Parejo-Alonso, B., & Sancho, P. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00203 · Cited by 154
Cancer’s Fuel Choice: New Flavors for a Picky Eater
DeNicola, G. M., & Cantley, L. C. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.018 · Cited by 146
Self-citationOxidative Phosphorylation: A Target for Novel Therapeutic Strategies Against Ovarian Cancer
Nayak, A. P., Kapur, A., Barroilhet, L. M., & Patankar, M. S. (2018) · Cancers · doi:10.3390/cancers10090337 · Cited by 161
Carugo, A., Genovese, G., Seth, S., Nezi, L., Rose, J. L., Bossi, D., Cicalese, A., Shah, P. K., Viale, A., Pettazzoni, P. F., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.063 · Cited by 141
Self-citationDrug-Tolerant Persister Cells in Cancer Therapy Resistance
Dhanyamraju, P. K., Schell, T. D., Amin, S., & Robertson, G. P. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-3844 · Cited by 161
Divakaruni, A. S., & Jastroch, M. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00619-4 · Cited by 176
Mitochondrial complex I promotes kidney cancer metastasis
Bezwada, D., Perelli, L., Lesner, N. P., Cai, L., Brooks, B., Wu, Z., Vu, H., Sondhi, V., Cassidy, D. L., Kasitinon, S. Y., et al. (2024) · Nature · doi:10.1038/s41586-024-07812-3 · Cited by 165
Self-citationERRα-Regulated Lactate Metabolism Contributes to Resistance to Targeted Therapies in Breast Cancer
Park, S., Chang, C.-Y., Safi, R., Liu, X., Baldi, R., Jasper, J. S., Anderson, G. R., Liu, T., Rathmell, J. C., Dewhirst, M. W., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.026 · Cited by 143
Rohlenová, K., Sachaphibulkij, K., Štursa, J., Bezawork‐Geleta, A., Blecha, J., Endaya, B., Werner, L., Černý, J., Zobalová, R., Goodwin, J., et al. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6677 · Cited by 144
Senkowski, W., Zhang, X., Olofsson, M. H., Isacson, R., Höglund, U., Gustafsson, M., Nygren, P., Linder, S., Larsson, R., & Fryknäs, M. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0792 · Cited by 141
Fernandez, H. R., Gadre, S. M., Tan, M., Graham, G. T., Mosaoa, R., Ongkeko, M. S., Kim, K. A., Riggins, R. B., Parasido, E., Petrini, I., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-018-0101-z · Cited by 139
Autophagy and cancer: Modulation of cell death pathways and cancer cell adaptations
Towers, C. G., Wodetzki, D., & Thorburn, A. (2019) · The Journal of Cell Biology · doi:10.1083/jcb.201909033 · Cited by 135
Sun, Y., Daemen, A., Hatzivassiliou, G., Arnott, D., Wilson, C., Zhuang, G., Gao, M., Liu, P., Boudreau, A., Johnson, L., et al. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-20 · Cited by 137
Metadata
- Authors
- Viale, A., Pettazzoni, P., Lyssiotis, C. A., Ying, H., Sánchez, N., Marchesini, M., Carugo, A., Green, T., Seth, S., Giuliani, V., Kost-Alimova, M., Muller, F., Colla, S., Nezi, L., Genovese, G., Deem, A. K., Kapoor, A., Yao, W., Brunetto, E., Kang, Y., Yuan, M., Asara, J. M., Wang, Y. A., Heffernan, T. P., Kimmelman, A. C., Wang, H., Fleming, J. B., Cantley, L. C., DePinho, R. A., & Draetta, G. F.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Weill Cornell Medicine (US)
- IRCCS Ospedale San Raffaele (IT)
- Beth Israel Deaconess Medical Center (US)
- Dana-Farber Cancer Institute (US)
- Corresponding author
- Viale, Andrea
- Draetta, Giulio F.
- ORCID
- Viale, Andrea
- Pettazzoni, Piergiorgio
- Lyssiotis, Costas A.
- Ying, Haoqiang
- Sánchez, Nora
- Marchesini, Matteo
- Carugo, Alessandro
- Seth, Sahil
- Giuliani, Virginia
- Colla, Simona
- Nezi, Luigi
- Genovese, Giannicola
- Deem, Angela K.
- Yao, Wantong
- Brunetto, Emanuela
- Kang, Ya’an
- Yuan, Min
- Asara, John M.
- Wang, Y. Alan
- Heffernan, Timothy P.
- Kimmelman, Alec C.
- Wang, Huamin
- Fleming, Jason B.
- Cantley, Lewis C.
- DePinho, Ronald A.
- Draetta, Giulio F.
- Venue
- Nature
- Published
- 2014-08-10
- Volume
- 514
- Issue
- 7524
- Pages
- 628-632
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4376130
- OpenAlex
- W2023300506
- Semantic Scholar
- 819eeeb41f6e84dd5c00221a269e91238736c4ad
- Cited by
- 1,259
- References
- 125
- Citations by year
- 2026: 93 · 2025: 72 · 2024: 104 · 2023: 105 · 2022: 119 · 2021: 131 · 2020: 135 · 2019: 114 · 2018: 105 · 2017: 90 · 2016: 99 · 2015: 81 · 2014: 8
- FWCI
- 44.61
- Type
- journal article
- Language
- en
- Update notices
- correction (2026-04-08)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (P50CA127003, CA-16672, CA 016672, P01CA120964, P30CA016672, P01CA117969)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- pancreatic ductal adenocarcinoma, KRAS mutation, tumor recurrence, oxidative phosphorylation, mitochondrial respiration, cancer stem cells, autophagy, glycolysis, OXPHOS inhibitors, combination therapy
- MeSH terms
- Animals, Autophagy, Cell Survival, Disease Models, Animal, Female, Glycolysis, Lysosomes, Mitochondria, Mutation, Neoplasm Recurrence, Local, Oxidative Phosphorylation, Pancreatic Neoplasms, Recurrence, Neoplastic Stem Cells, Signal Transduction, Gene Expression Regulation, Neoplastic, Genes, p53, Proto-Oncogene Proteins p21(ras), Cell Respiration, Carcinoma, Pancreatic Ductal, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.